Article Information
History
- March 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michael E. G. Rosch1,#,
- Jacqueline Rehner2,#,
- Georges P. Schmartz3,#,
- Sascha K. Manier4,
- Uta Becker5,
- Rolf Müller6,
- Markus R. Meyer4,
- Andreas Keller3,
- Sören L. Becker2 and
- Verena Keller3,*
- 1Medical Doctor program Human Medicine, Saarland University/ Saarland University Medical Center, Saarbrücken/Homburg, 66123/66421, Germany
- 2Institute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, 66421, Germany
- 3Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, 66123, Germany
- 4Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Center for Molecular Signaling (PZMS), Homburg/Saar, 66421, Germany
- 5MIP Pharma GmbH, Sankt Ingbert, 66386, Germany
- 6Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, 66123, Germany
- ↵*To whom correspondence should be addressed. Tel: +49 0684116 15146; Email: verena.keller{at}uks.eu
↵# Authors contributed equally.